Global Population Health Strategy Lead, Autoimmune Diabetes (T1D)
Global Population Health Strategy Lead Autoimmune Diabetes (T1D)
At Sanofi, we are driven by one purpose – we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Diabetes (Type 1 Diabetes).
Our newest core asset, resulting from the acquisition of Provention Bio in General Medicines Autoimmune Type 1 Diabetes space, aims at delaying the onset of stage 3 type 1 diabetes. This means that for the first time, people at risk of developing this lifelong disease have fresh hope. What delayed onset means is more time for children to be children with less healthcare and more care-free childhood. The delay also gives families and healthcare professionals more time to prepare care plans for a later diagnosis.
We now present an exciting opportunity for you to go further faster. If you’re excited by the prospect of bringing this innovative, first-in-class therapy to more people at risk then we want to hear from you as we build a great team who will work at the intersection of our growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet need.
This is a chance to bring your energy, expertise and experience to truly transformative and career-defining leadership roles where you can help change countless lives. In return, you will have a rare opportunity in pharma – the chance to help disrupt and delay a debilitating and widespread disease.
This really is a ‘prime time’ role offering you huge visibility and the chance to fast-track your career in healthcare.
Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.
Our Autoimmune Type 1 Diabetes journey starts now and you can help us chart a new course – not only for Sanofi but for preventive healthcare. Now is the time to add your strengths to ours!
Global Population Health Strategy Lead – you are an experienced and successful business leader who can flex across a breadth of leadership skills including strategic thinking, problem solving and business plan design through to execution. You have a history of strong performance in previous roles, you are an adaptable leader who can find a way to bring together and lead cross-functional teams to deliver positive outcomes for customers, patients, and Sanofi. You thrive on the challenge to do things differently, operate with ambiguity and find business solutions to new business challenges. You thrive in a space where there are no precedents and are comfortable and confident enough to shape old new ways forward. You are comfortable in both commercial and scientific discussions, have driven/built innovative strategies and solutions, have experience in brokering partnerships and ultimately are patient centric.
This role reports into the Global Head of Autoimmune Diabetes. You will be leading the global population health strategy at identifying patients at risk for a first-in-class, monoclonal antibody specialty disease launch working in conjunction with countries and global functions. The patient acquisition business plan requires a unique design to ensure the identification of at-risk people through screening and monitoring. The scope includes collaborating with other functions (especially Medical) to define strategic partnerships and investments with health authorities, scientific bodies, KOLs to build consensus towards the adoption of national screening programs (currently white space in several countries) and execution of critical activities. Once the strategy is shaped your role will be also to activate and co-ordinate approaches across several functions at both global and local level.
Defines the to-be screening and monitoring landscape (e.g., screening infrastructures, data-driven solutions) and builds long-term strategy, incl. identification of quick wins to drive short-term impact
Builds and manages strategic partnerships: develops commercial partnerships (e.g., with CGM, telemedicine companies, EMR) in collaboration with BD&L team and sets-up partnerships with testing infrastructure ecosystem players (e.g., with diagnostic labs and companies)
Maps the healthcare ecosystem: Profiles CoEs and infusion setups, Pediatricians’ and Endocrinologists’ roles in the healthcare system and maps current referral pathways
Defines optimal referral pathway strategy (incl. digital solutions) for seamless people at risk/ patient journeys across the healthcare system
Collaborates with the Global Patient Experience Lead to inform the end-to-end patient journey development
Develops screening and monitoring content campaigns, engagement planning (e.g., with screening infrastructure players) and key investment strategy
Defines KPIs to measure people at risk identification and tracks against targets
Assesses and manages risks around screening and monitoring in collaboration with Ethics & Business Integrity and Legal teams
Seasoned business leader with a strong background in national health initiatives, or launching products requiring population health monitoring/screening
Has contributed/ideated successful global launch experience in Specialty / Rare disease/ Type 1 Diabetes
Experience in building partnerships in screening/diagnostics ecosystem
Robust experience with leading the large complex Planning process, strategy, insights and analytics through to plan pull-through.
Strong financial acumen – experience with resource allocation, P&L management
Good communication skills, ability to communicate to audiences of varied sizes and levels
Strong PMO skills with the ability to lead, simplify and move at pace, large complex programs
Delivered launches in new green field therapy areas
Pursue progress, discover extraordinary
Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.
At Sanofi, we provide equal opportunities to all regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity.
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.